Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Hongyi Technology is a high-growth life sciences automation company based in Shanghai, China, specializing in high-throughput laboratory solutions. Founded in 2021 by a leadership team with extensive experience at global industry leaders like Hamilton and Beckman Coulter, the company develops high-performance automated liquid handling workstations and integrated robotic systems. Its flagship H-PRO series and H-FLOW platforms are designed to streamline complex laboratory workflows in genomics, drug discovery, synthetic biology, and clinical diagnostics. Hongyi Technology positions itself as a premium provider of domestic laboratory infrastructure, aiming to provide high-precision alternatives to international brands through advanced motion control and modular software. The company has secured significant venture capital backing from top-tier investors including Sequoia China, SoftBank, and Matrix Partners to support its R&D and global expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hongyi Technology.